New synthetic surfactant - how and when?

Area of Science:

• Neonatal Medicine
• Biochemistry
• Materials Science

Background:

• Animal-derived surfactant preparations are effective for premature infants with respiratory distress syndrome (RDS).
• High production costs and limited supplies of animal-derived surfactants necessitate the development of synthetic alternatives.
• Existing synthetic surfactant development faces challenges due to the complexity of essential hydrophobic proteins (SP-B, SP-C).

Purpose of the Study:

• To address the need for cost-effective, large-scale synthetic surfactant preparations for RDS treatment.
• To explore novel synthetic surfactant formulations that overcome the limitations of previous attempts.

Main Methods:

• Investigating simplified phospholipid mixtures for surfactant formulations.
• Incorporating small synthetic peptides to replace the function of hydrophobic surfactant proteins (SP-B, SP-C).
• Developing a new generation of synthetic surfactant preparations for clinical evaluation.

Main Results:

• The development of synthetic surfactants has proven more complex than initially anticipated.
• Hydrophobic surfactant proteins (SP-B, SP-C) are difficult to synthesize or are unstable in pure form.
• A new generation of synthetic surfactants utilizing simplified phospholipids and peptides is under development.

Conclusions:

• Synthetic surfactants offer a potential solution to the cost and supply limitations of animal-derived treatments.
• Further clinical trials are required to ascertain the efficacy of new peptide-based synthetic surfactants compared to natural preparations.
• The introduction of these novel synthetic surfactants into the market is anticipated in the near future.